(TransPot) Translational Research Network in Prostate Cancer
The Translational Research Network for Prostate Cancer (TransPot) program adopts an innovative, multidisciplinary approach, providing highly sought-after, effective solutions for incurable prostate cancer (PC). The TransPot scientific objective is to obtain an unmatched depth of molecular, mechanistic and informatics systems-level disease understanding in order to improve the prognosis and treatment of lethal PC, aimed to (i) provide important insights into molecular mechanisms driving treatment resistant PC including castrate-resistant PC (CRPC), (ii) identify novel therapeutic targets, (iii) develop and validate predictive models for disease progression, prognosis and responsiveness to current and novel (co-)treatment options, and (iv) provide superior, clinically relevant tools and biomarker signatures for personalising and optimising CRPC therapy.
The central aim of TransPot is to provide a multi-disciplinary research training programme integrating cancer biology and systems medicine to train young researchers to become future successful leaders in cancer research. It will provide ESRs with a solid base for a career in translational research in either academia or industry.
More detailed information
Dr. ir. Wytske van Weerden
Role Erasmus MC: